X-linked intellectual disability (XLID) refers to a clinically and genetically heterogeneous neurodevelopmental disorder, in which males are more heavily affected than females. Among the syndromic forms of XLID, identified by additional clinical signs as part of the disease spectrum, the association between XLID and severe myopia has been poorly characterized. We used whole exome sequencing (WES) to study two Italian male twins presenting impaired intellectual function and adaptive behavior, in association with severe myopia and mild facial dysmorphisms.
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WES analysis detected the novel, maternally inherited, mutation c.916G > C (G306R) in the Xlinked heparan sulfate 6-O-sulfotransferase 2 (HS6ST2) gene. HS6ST2 transfers sulfate from adenosine 3 0 -phosphate, 5 0 -phosphosulfate to the sixth position of the N-sulphoglucosamine residue in heparan sulfate (HS) proteoglycans. Low HS sulfation levels are associated with defective optic disc and stalk morphogenesis during mammalian visual system development. The c.916G>C variant affects the HS6ST2 substrate binding site, and its effect was considered "deleterious" by in-silico tools. An in-vitro enzymatic assay showed that the HS6ST2 mutant isoform had significantly reduced sulphotransferase activity. Taken together, the results suggest that mutant HS6ST2 is possibly involved in the development of myopia and cognitive impairment, characteristics of the probands reported here.
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| INTRODUCTION
Intellectual disability (ID) is defined as a neurodevelopmental disorder with onset before 18 years of age, characterized by IQ ≤ 70 and deficit in at least two adaptive behaviors (eg, communication, self-care). 1 ID occurs in approximately 1% to 3% of the population 2 and has a variety of environmental and genetic causes, which are frequently present in combination with one another. 3 Mild ID is typically 
| Bioinformatic analyses
In silico prediction of the functional effect of the c.916G>C mutation on the HS6ST2 gene was performed using the "Mutation Taster" tool.
At the protein level, the consequences of the Gly306Arg substitution on HS6ST2 tertiary structure were evaluated using Phyre2 software (Protein Homology-fold Recognition Server; www.sbg.bio.ic.ac.uk/ phyre2/). Wild-type and mutated HS6ST2 3D structures were modelled. 9 These analyses were implemented using Phyre investigator, a workbench analysis tool with additional features for investigation of models created using Phyre2. All *.pdb files generated using Phyre2
were loaded and visualized with ChemDraw (version 8; Cambridge
Software; PerkinElmer, Inc., Waltham, Massachusetts).
| HS6ST2 site-directed mutagenesis
The mammalian pReceiver-M12 Ampr vector containing the full length HS6ST2 cDNA isoform (NM_001077188.1, ENST00000521489.5)
fused to an N-terminal 3× Flag-tag (tebu-bio) was used as template to generate a HS6ST2 c. 
| Assay of HS6ST2 activity
The enzymatic activity of HS6ST2 was assayed in cell extracts from and one brother (FII-3). The probands came to our attention when they were 5 years old, after a diagnosis of severe psychomotor delay.
Karyotype and comparative genomic hybridization (CGH) array results
were normal, and they were negative for FMR1 repeat expansion. The clinical features of the probands are detailed in Table 1 . Both had neurodevelopmental impairment, classified as "severe" according to the
Griffith scale (score = 34), and speech delay. They began walking at 2 years old and could speak only poorly at 5 years old. A routine growth checkup at 5 years old revealed weight in the 10th and height in the 25th percentiles. In the first year of life, they suffered from 
| Mutation analysis by NGS
Using WES analysis, we identified the hemizygous single-nucleotide HS6ST2 have been identified and exhibit tissue-specific localization: full length HS6ST2 is expressed in the eyes and brain during embryonic development, and a short form of the gene, hHS6ST-2S, encoding 40 fewer amino acids, has been detected in the ovary, placenta, and fetal kidney. 12 Both isoforms catalyze the same sulfation reaction. 13 The novel G>C transversion in HS6ST2 identified here changes a GGC codon, encoding a non-polar glycine residue, to a CGC, which encodes a positively charged arginine. The variant was present in the affected triplets (FII-1 and FII-2), carried by the healthy mother, and absent in both the father and the unaffected brother (FII-3) (Figure 1 ).
Sanger sequencing confirmed the findings of NGS and the segregation of the transversion in the family. The "Mutation Taster" in silico prediction tool classified the c.916G>C substitution as deleterious, with a score of 1.000 (values close to 1 indicate a high "security" of prediction). This substitution has never been reported in the main databases of nucleotide variants, including dbSNP, 1000 Genomes, and Exac (Appendix S1).
| In silico 3D modeling of the HS6ST2-G306R protein
The 
| In vitro assay of HS6ST2-G306R activity
To test whether G306R variant affects HS6ST2 enzyme expression and/or activity, HEK293 cells were transiently transfected with the empty vector (mock control) and with plasmids expressing wild-type (HS6ST2-WT) or G306R mutant (HS6ST2-G306R) FLAG-HS6ST2. We first analyzed the expression of recombinant wild-type and mutant HS6ST2 proteins in HEK293 cells. Protein expression was undetectable in mock-transfected cells but was evident in the HS6ST2-WT and HS6ST2-G306R transfected cells. As shown in Figure 3A , the expression levels of the wild-type and mutant proteins were very similar.
Next, we examined HS6ST2 activity using HS as a substrate. In mock-transfected HEK293 cells, HS6ST2 activity was 2.7 AE 20.6 , we next evaluated the effect of DTT on enzyme activity. As shown in Figure 3C , DTT caused an approximately 3-fold decrease in both wild-type and G306R enzyme activity, from 100% to 32% AE 13% (P = 0.0039, two-tailed t test) and from 38% AE 8% to 12% AE 2% (P = 0.047, two-tailed t test), respectively.
| DISCUSSION
In this study, WES was performed to characterize genetically two affected monozygotic twins with an inconclusive clinical diagnosis. We detected a novel pathogenic variant of the X-linked HS6ST2 gene associated with a very unusual combination of syndromic ID and severe congenital myopia. The deleterious effect of the mutant enzyme was predicted using in silico tools and confirmed by an in vitro functional assay.
The pedigree of the family included in this study was consistent with the presence of a de novo variant or with recessive autosomal or X-linked inheritance, and filtering processes revealed the missense substitution c.916G>C in the HS6ST2 gene as the unique candidate variant with high confidence. This variant was never been previously reported and encodes HS6ST2, which transfers sulphate from PAPS to the N-sulphoglucosamine (GlcNS) residue in HS proteoglycans.
Severe myopia is arbitrarily defined as short sightedness greater than six diopters. 14 It is usually an isolated disorder; however, more rarely, it can be associated with syndromic conditions (eg, Stickler syndrome). 15 Recently forms of syndromic myopia, 13 were X-linked, and among them only
Danon syndrome was sporadically associated with ID. 16 HSPGs are ubiquitous components of the cell surface, extracellular matrix, and basement membranes, and interact with various ligands to influence cell growth, differentiation, adhesion, and migration. defective optic disc and stalk morphogenesis during mammalian visual system development. 13 Altered HS6ST2 expression has been identified in numerous human cancers, 17 and is reported to participate in the pathogenesis of osteoarthritis and Kashin-Beck disease. 18 To date, there is no evidence of HS6ST2 involvement in Mendelian diseases.
The Face2Gene phenotyping tool identified a slight similarity of the phenotype of the affected boys with that of BWB syndrome, a condition described by Brooks et al., Morava et al., and Friez et al. [19] [20] [21] [22] ID, speech delay, and severe myopia in a context of mild dysmorphia were the specific key features supporting the similarity. Moreover, the three BWB patients described by Morava et al. 21 presented with increased blood lactate values in infancy, similar to the affected twins.
Despite this, WES analysis excluded the presence of pathogenic variants of the HUWE1 gene, which was identified by Friez et al. as a causal gene for BWB. 22 In addition, there were clinical discrepancies between the affected probands and the BWB patients described in the literature. The boys described by Brooks et al. 19 presented with spastic diplegia, optic and cerebellar atrophy, and entropion, which
were not noted in our cases; the majority of patients reported by Morava 20, 21 exhibited regression, seizures, and corpus callosum hypogenesis that were not present in the patients described in the current study. Given that BWB syndrome is an extremely rare disorder and exhibits a high degree of clinical heterogeneity, [19] [20] [21] [22] it is possible that BWB could be genetically heterogeneous and that the phenotype of 23 HS have been specifically noted in eye development, cranial axon guidance, and motor neuron migration. 24, 25 In a mouse model, abnormally low sulfation of HS allows normal retinal neurogenesis and optic fissure closure; however, it leads to defective optic disc and stalk development. 24 Adult mutant animals develop optic nerve aplasia/hypoplasia and exhibit retinal degeneration. 24 Although myopia is not directly related to optic nerve aplasia/ hypoplasia, but rather occurs if the eyeball is too long or the cornea is too curved, a link may exist between the mutation detected in the HS6ST2 gene and the severe myopia observed in the affected children. FIGURE 3 Expression and activity of HS6ST2 in mock, wild type and G306R mutant cells. HEK293 cells were transiently transfected with empty vector (mock), or with plasmids expressing wild-type FLAG-HS6ST2 (WT), or mutant FLAG-G306R (G306R), and then subjected to immunoblot analysis (A), and the HS6ST2 assay (B and C). A, representative immunoblot image of HS6ST2 expression in mock, wild type and G306R mutant cells. β-actin was used as loading control. B and C, HS6ST2 activity in the cell extracts of mock, WT and G306R cells. Enzyme activity was assayed as described in Materials and Methods in the absence (B) or presence (C) of 10 mM dithiothreitol (+ DTT). In all cases, the reaction rate was linear with enzyme protein and incubation time. Data are the mean AE SD of three individual assays. Statistical significance was assessed using two-tailed Student's t test; **P < 0.01
In conclusion, we identified a novel c.916G>C variant in the HS6ST2 gene. The mutation caused a significantly reduction in HS6ST2 6-O-sulfotransferase activity and was associated with a previously undescribed form of syndromic XLID with severe congenital myopia. Although the phenotype of the probands in this study is weakly similar to BWB, the underlying genetic cause differs. A hypothesis could suggest possible loci and pathway heterogeneity in BWB syndrome. Alternatively, HS6ST2 may cause a novel clinical condition and be pivotal for the development of myopia and cognitive impairment. Although the current report describes only a single pedigree, it could be used by clinicians to facilitate recognition of similar families and to provide a more accurate genetic counseling.
